» Articles » PMID: 30853886

Amyloid β Induces Early Changes in the Ribosomal Machinery, Cytoskeletal Organization and Oxidative Phosphorylation in Retinal Photoreceptor Cells

Abstract

Amyloid β (Aβ) accumulation and its aggregation is characteristic molecular feature of the development of Alzheimer's disease (AD). More recently, Aβ has been suggested to be associated with retinal pathology associated with AD, glaucoma and drusen deposits in age related macular degeneration (AMD). In this study, we investigated the proteins and biochemical networks that are affected by Aβ in the 661 W photoreceptor cells in culture. Time and dose dependent effects of Aβ on the photoreceptor cells were determined utilizing tandem mass tag (TMT) labeling-based quantitative mass-spectrometric approach. Bioinformatic analysis of the data revealed concentration and time dependent effects of the Aβ peptide stimulation on various key biochemical pathways that might be involved in mediating the toxicity effects of the peptide. We identified increased Tau phosphorylation, GSK3β dysregulation and reduced cell viability in cells treated with Aβ in a dose and time dependent manner. This study has delineated for the first-time molecular networks in photoreceptor cells that are impacted early upon Aβ treatment and contrasted the findings with a longer-term treatment effect. Proteins associated with ribosomal machinery homeostasis, mitochondrial function and cytoskeletal organization were affected in the initial stages of Aβ exposure, which may provide key insights into AD effects on the photoreceptors and specific molecular changes induced by Aβ peptide.

Citing Articles

Cross-disease modeling of peripheral blood identifies biomarkers of type 2 diabetes predictive of Alzheimer's disease.

Ball B, Park J, Proctor E, Brubaker D bioRxiv. 2024; .

PMID: 39713369 PMC: 11661382. DOI: 10.1101/2024.12.11.627991.


A transient protein folding response targets aggregation in the early phase of TDP-43-mediated neurodegeneration.

San Gil R, Pascovici D, Venturato J, Brown-Wright H, Mehta P, Madrid San Martin L Nat Commun. 2024; 15(1):1508.

PMID: 38374041 PMC: 10876645. DOI: 10.1038/s41467-024-45646-9.


Amyloid-beta and tau protein beyond Alzheimer's disease.

Abyadeh M, Gupta V, Paulo J, Mahmoudabad A, Shadfar S, Mirshahvaladi S Neural Regen Res. 2023; 19(6):1262-1276.

PMID: 37905874 PMC: 11467936. DOI: 10.4103/1673-5374.386406.


Oxidative Stress Induced Dysfunction of Protein Synthesis in 661W Mice Photoreceptor Cells.

Deng L, Gupta V, Abyadeh M, Chitranshi N, Pushpitha K, Wu Y Proteomes. 2023; 11(2).

PMID: 37092453 PMC: 10123756. DOI: 10.3390/proteomes11020012.


Quantitative proteomics of sperm tail in asthenozoospermic patients: exploring the molecular pathways affecting sperm motility.

Mirshahvaladi S, Rezaei Topraggaleh T, Bucak M, Rahimizadeh P, Shahverdi A Cell Tissue Res. 2023; 392(3):793-810.

PMID: 36847810 DOI: 10.1007/s00441-023-03744-y.


References
1.
Ding Q, Markesbery W, Chen Q, Li F, Keller J . Ribosome dysfunction is an early event in Alzheimer's disease. J Neurosci. 2005; 25(40):9171-5. PMC: 6725754. DOI: 10.1523/JNEUROSCI.3040-05.2005. View

2.
Sinha D, Valapala M, Shang P, Hose S, Grebe R, Lutty G . Lysosomes: Regulators of autophagy in the retinal pigmented epithelium. Exp Eye Res. 2015; 144:46-53. PMC: 4698066. DOI: 10.1016/j.exer.2015.08.018. View

3.
Ratnayaka J, Serpell L, Lotery A . Dementia of the eye: the role of amyloid beta in retinal degeneration. Eye (Lond). 2015; 29(8):1013-26. PMC: 4541342. DOI: 10.1038/eye.2015.100. View

4.
Guo L, Salt T, Luong V, Wood N, Cheung W, Maass A . Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci U S A. 2007; 104(33):13444-9. PMC: 1940230. DOI: 10.1073/pnas.0703707104. View

5.
Liu R, Gao J, Cao S, Sandhu N, Cui J, Chou C . Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2013; 54(3):2225-37. PMC: 3947398. DOI: 10.1167/iovs.12-10849. View